drugset / Trial / NCT04578938

Ketamine + Cognitive Training for Suicidality in the Medical Setting

NCT04578938 ↗

Phase 4 Active not recruiting 200 enrolled Rebecca Price National Institute of Mental Health (NIMH) · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

This project seeks to identify the acute and longer-term impact of a single dose of intravenous ketamine among suicidal patients referred for psychiatric consultation/liaison in the medical inpatient setting. The investigators will then test whether ketamine's rapid effects can be extended by introducing helpful information delivered by a computer-based training protocol. This work could ultimately lead to the ability to treat suicidality more efficiently and with broader dissemination by rapidly priming the brain for helpful forms of learning.

Timeline

Start
2021-03-15
Primary completion
2026-12-02
Completion
2026-12-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.5 mg/kg Intravenous

Indications

No indication recorded.